Alignment Healthcare (ALHC) Expected to Release Quarterly Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is anticipated to announce its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect Alignment Healthcare to announce earnings of ($0.0389) per share and revenue of $1.31 billion for the quarter. Individuals may review the information on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, October 29, 2026 at 5:00 PM ET.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The business had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. During the same period in the prior year, the firm earned $0.07 EPS. Alignment Healthcare’s quarterly revenue was up 31.6% compared to the same quarter last year. On average, analysts expect Alignment Healthcare to post $0.14 EPS for the current fiscal year and $0.30 EPS for the next fiscal year.

Alignment Healthcare Stock Performance

NASDAQ:ALHC opened at $7.89 on Tuesday. Alignment Healthcare has a 1 year low of $6.01 and a 1 year high of $25.12. The firm’s fifty day simple moving average is $10.29 and its 200 day simple moving average is $17.09. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 1.22. The firm has a market capitalization of $1.64 billion, a PE ratio of 41.53 and a beta of 1.14.

Wall Street Analyst Weigh In

ALHC has been the subject of a number of research analyst reports. William Blair lowered shares of Alignment Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, October 9th. Weiss Ratings downgraded Alignment Healthcare from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, October 9th. TD Cowen lowered their price target on Alignment Healthcare from $21.00 to $12.00 and set a “buy” rating on the stock in a research report on Monday, October 12th. Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, KeyCorp cut their price objective on Alignment Healthcare from $28.00 to $12.00 and set an “overweight” rating for the company in a research report on Friday, October 9th. Seven research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.91.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, EVP Joseph S. Konowiecki sold 23,511 shares of the company’s stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $8.61, for a total value of $202,429.71. Following the completion of the transaction, the executive vice president owned 1,080,305 shares of the company’s stock, valued at $9,301,426.05. This represents a 2.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, President Dawn Maroney sold 122,707 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $12.68, for a total value of $1,555,924.76. Following the completion of the sale, the president owned 794,606 shares of the company’s stock, valued at $10,075,604.08. This represents a 13.38% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 1,061,967 shares of company stock worth $13,642,490 in the last three months. Corporate insiders own 5.20% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc is a technology-enabled health insurance company focused on providing Medicare Advantage plans for seniors. The company combines health plan coverage with care coordination and clinical services designed to help members manage chronic conditions, access providers and navigate the health care system.

Its offerings include Medicare Advantage plans, supplemental benefits and member support services. Alignment also uses its proprietary technology platform, including the Alignment Virtual Application (AVA), to support care teams, analyze health information and help deliver more personalized services to members.

Founded in 2013, Alignment Healthcare serves Medicare-eligible consumers in selected markets, including California, Florida, Nevada and North Carolina.